Immunomedics, Inc.

  • Oncology Account Manager- Omaha

    Job Locations US-NE | US-SD | US-IA
    Posted Date 1 month ago(11/4/2019 3:36 PM)
    Job ID
    # of Openings
  • Overview

    We currently seek motivated professionals who share our passion for science and our dedication to improving the lives of cancer patients. The Oncology Sales Specialist, is a key position within the Immunomedics commercial team. The position will report to the Regional Business Director.


    • The Oncology Sales Specialist will be responsible for launching Immunomedics oncology products within the assigned territory.
    • Key activities include promoting all assigned products to targeted oncologists and office staff, working with reimbursement and office management to ensure product reimbursement, in-servicing all staff to ensure safe and appropriate drug administration,
    • Developing thought-leaders and advocate development
    • Providing feedback on the marketplace to the RBD and product marketing
    • Building strong relationships with other key stakeholders to enable product adoption.


    • Bachelor’s degree in Business, Nursing or related field. (MA,MBA a plus)
    • Minimum of 3-5 years of biopharmaceutical oncology or hematology sales experience with documented track record of success in this marketplace.
    • Product launch Experience.
    • Experience in hospital and large account sales, managing through complex reimbursement issues.
    • Strong written and verbal communication skills, solid presentation skills and ability to influence others.
    • Demonstrated ability to establish and maintain strong business relationships
    • Candidates must be able to demonstrate knowledge of customer business, disease state, product/competitive prescribing information, approved promotional clinical trials, patient/office access to medication, contract terms and conditions, and regulatory/compliance guidelines
    • Must have a valid US driver’s license.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed